Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis
Open Access
- 6 March 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 648
Abstract
Background: Membranoproliferative glomerulonephritis (MPGN) is an umbrella term for chronic disorders affecting the glomeruli. MPGN is often accompanied by the presence of autoantibodies against complement components. However, the actual pathogenic effects of such autoantibodies, if any, are rarely studied. In this work, we investigated the role of anti-complement autoantibodies in an IC-MPGN patient. Methods: The presence of autoantibodies, their binding site, isotype, and titer were analyzed in ELISA. Antibody–antigen complexes were detected in the patient’s serum using Western blot. Autoantibodies were studied in functional assays to analyze their effects on C3 convertase, complement deposition, cofactor activity, C3b binding, and hemolysis. Results: We identified autoantibodies against factor B (FB) and factor H (FH) in the patient’s serum. Both FB-, and FH-autoantibodies were of IgG2, IgG3, IgG4, and IgGκ, IgGλ isotypes. FB-autoantibodies bound to the Ba and the enzymatically active Bb part of FB. FH-autoantibodies bound to the N- and C-termini of FH and cross-reacted with FHL-1 and FHR-1 proteins. In vivo formed complexes of the autoantibodies with both FB and FH were detected in the IgG fraction isolated from the serum. The autoantibodies did not influence solid-phase C3 convertase assembly and its FH-mediated decay. The free autoantibodies had no effect on complement deposition and on FH cofactor activity but slightly reduced C3b binding to FH. The IgG fraction of the patient dose-dependently inhibited complement-mediated rabbit red blood cell lysis, and the free autoantibodies decreased the solid phase C3 convertase activity. Conclusions: This case highlights that FB- and FH-autoantibodies are not necessarily pathogenic in IC-MPGN.Keywords
Funding Information
- Hungarian Research Network (0106307, 899163 (SciFiMed), 2023-1.2.1-ERA_NET-2023-00014)
- European Union’s Horizon 2020 Research and Innovation Programme (0106307, 899163 (SciFiMed), 2023-1.2.1-ERA_NET-2023-00014)
- Eötvös Loránd University (0106307, 899163 (SciFiMed), 2023-1.2.1-ERA_NET-2023-00014)
- European Joint Programme on Rare Diseases EJPRD2022-016 COMPRare (0106307, 899163 (SciFiMed), 2023-1.2.1-ERA_NET-2023-00014)
- Kidneeds (Iowa, USA) (0106307, 899163 (SciFiMed), 2023-1.2.1-ERA_NET-2023-00014)
This publication has 61 references indexed in Scilit:
- Anti-factor B antibodies in atypical hemolytic uremic syndromePediatric Nephrology, 2024
- Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 GlomerulopathyKidney International Reports, 2023
- Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunctionAutoimmunity Reviews, 2023
- A clinical approach to children with C3 glomerulopathyPediatric Nephrology, 2021
- Anti-complement factor H autoantibodies may be protective in lupus nephritisClinica Chimica Acta, 2020
- Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathyPediatric Nephrology, 2018
- Complement analysis 2016: Clinical indications, laboratory diagnostics and quality controlImmunobiology, 2016
- Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndromeImmunology Letters, 2014
- Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulationPediatric Nephrology, 2010
- A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytesJournal of Immunological Methods, 1982